Autor/in Al-Sakaff, N Ataseven, B 1 Azim, H A 1 De Laurentiis, M 1 Gligorov, J 1 Jung, K H 1 Lauer, S 1 Pivot, X 1 Shing, M 1 Verrill, M 1 alle zeigenListe einklappen
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer:SafeHer phase III study's primary analysis of 2573 patients Gligorov, J Ataseven, B Verrill, M De Laurentiis, M Jung, K H Azim, H A Al-Sakaff, N 2017 - Forschungsinformationssystem des UKE
